Outlook 2024
Annual Industry Ranking And Forecast
Scrip 100
The latest Scrip 100 data set is now available and includes data on R&D spending, total revenues, employee numbers and sales for the top 100 biopharmaceutical companies (based on FY 2022).
If you are a subscriber, you may download the data in Excel format.
Industry Leaderboard Gains And Dips Were Still Marked By COVID-19
Pfizer held the number one spot on the Scrip 100 on the strength of its COVID-19 products, while some others faced challenging financial comparisons in 2022 because of COVID-19 headwinds.
Scrip 100: By The Numbers
Pfizer dominated the Scrip 100 rankings of the top pharmaceutical companies in the world based on full year 2022 pharmaceutical sales, driven by its COVID-19 success.
Chapter sponsored by:
Exploring Use Cases For
Tokenizing Clinical Trials
Traditional clinical studies can be costly, time consuming and burdensome on patients and sites. As a result, researchers are looking for new and innovative solutions to answer challenging research questions. One of these solutions is Clinical Trial Tokenization.
Outlook 2024 e-Book
Download a PDF copy of the Outlook 2024 collection, including Scrip 100 league tables.
Scrip 100 Ranking
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.